The challenge to one-course carboplatin in seminoma clinical stage 1
- PMID: 27154420
- DOI: 10.1093/annonc/mdw187
The challenge to one-course carboplatin in seminoma clinical stage 1
Comment in
-
Reply to 'The challenge to one course carboplatin in seminoma clinical stage 1' by Dieckmann and Anheuser.Ann Oncol. 2016 Sep;27(9):1809. doi: 10.1093/annonc/mdw207. Epub 2016 May 13. Ann Oncol. 2016. PMID: 27177862 No abstract available.
Comment on
-
Treatment of stage I seminoma, with one course of adjuvant carboplatin or surveillance, risk-adapted recommendations implementing patient autonomy: a report from the Swedish and Norwegian Testicular Cancer Group (SWENOTECA).Ann Oncol. 2016 Jul;27(7):1299-304. doi: 10.1093/annonc/mdw164. Epub 2016 Apr 6. Ann Oncol. 2016. PMID: 27052649
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources